Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study

Undiagnosed and untreated non-alcoholic fatty liver disease (NAFLD) can lead to the development of many complications, such as cirrhosis, hepatocellular carcinoma, or cardiovascular diseases. Obese people are at increased risk of developing NAFLD. Due to the current lack of routine diagnostics, it i...

Full description

Bibliographic Details
Main Authors: Beata Zyśk, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka, Katarzyna Witczak-Sawczuk, Agnieszka Gornowicz, Anna Bielawska
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2891
_version_ 1797624230456590336
author Beata Zyśk
Lucyna Ostrowska
Joanna Smarkusz-Zarzecka
Katarzyna Witczak-Sawczuk
Agnieszka Gornowicz
Anna Bielawska
author_facet Beata Zyśk
Lucyna Ostrowska
Joanna Smarkusz-Zarzecka
Katarzyna Witczak-Sawczuk
Agnieszka Gornowicz
Anna Bielawska
author_sort Beata Zyśk
collection DOAJ
description Undiagnosed and untreated non-alcoholic fatty liver disease (NAFLD) can lead to the development of many complications, such as cirrhosis, hepatocellular carcinoma, or cardiovascular diseases. Obese people are at increased risk of developing NAFLD. Due to the current lack of routine diagnostics, it is extremely important to look for new diagnostic methods and markers for this disease. The aim of this study was to assess the concentration of selected pro-inflammatory adipokines and cytokines in the unstimulated saliva of obese people with fatty liver disease in various stages (with or without slight fibrosis) and to analyze them for possible use as early markers of NAFLD diagnosis. The study involved 96 people who were divided into 5 groups based on the criterion of body mass index (BMI) and the degree of fatty liver (liver elastography). There were statistically significant differences between the groups in the concentrations of MMP-9 (matrix metalloproteinase 9), resistin, and IL-1β (interleukin 1β) in saliva. Statistically significant, positive correlations between hepatic steatosis and the concentration of MMP-2 (matrix metalloproteinase 2), resistin, and IL-1β in saliva were also found. Statistically significant positive correlations were also found between the concentration of resistin in saliva and the concentration of ALT (alanine aminotransferase) and GGTP (gamma-glutamyl transpeptidase) in serum. MMP-2, IL-1β, and resistin may be potential markers of NAFLD development, assessed in saliva. However, further research is needed because this is the first study to evaluate the concentrations of the selected pro-inflammatory parameters in the saliva of patients with NAFLD.
first_indexed 2024-03-11T09:40:00Z
format Article
id doaj.art-8251ec65459b4407bd32f6308ff13058
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:40:00Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-8251ec65459b4407bd32f6308ff130582023-11-16T17:03:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01243289110.3390/ijms24032891Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot StudyBeata Zyśk0Lucyna Ostrowska1Joanna Smarkusz-Zarzecka2Katarzyna Witczak-Sawczuk3Agnieszka Gornowicz4Anna Bielawska5Department of Dietetics and Clinical Nutrition, Medical University of Bialystok, Mieszka I Street 4B, 15-054 Bialystok, PolandDepartment of Dietetics and Clinical Nutrition, Medical University of Bialystok, Mieszka I Street 4B, 15-054 Bialystok, PolandDepartment of Dietetics and Clinical Nutrition, Medical University of Bialystok, Mieszka I Street 4B, 15-054 Bialystok, PolandDepartment of Dietetics and Clinical Nutrition, Medical University of Bialystok, Mieszka I Street 4B, 15-054 Bialystok, PolandDepartment of Biotechnology, Medical University of Bialystok, Jana Kilinskiego Street 1, 15-089 Bialystok, PolandDepartment of Biotechnology, Medical University of Bialystok, Jana Kilinskiego Street 1, 15-089 Bialystok, PolandUndiagnosed and untreated non-alcoholic fatty liver disease (NAFLD) can lead to the development of many complications, such as cirrhosis, hepatocellular carcinoma, or cardiovascular diseases. Obese people are at increased risk of developing NAFLD. Due to the current lack of routine diagnostics, it is extremely important to look for new diagnostic methods and markers for this disease. The aim of this study was to assess the concentration of selected pro-inflammatory adipokines and cytokines in the unstimulated saliva of obese people with fatty liver disease in various stages (with or without slight fibrosis) and to analyze them for possible use as early markers of NAFLD diagnosis. The study involved 96 people who were divided into 5 groups based on the criterion of body mass index (BMI) and the degree of fatty liver (liver elastography). There were statistically significant differences between the groups in the concentrations of MMP-9 (matrix metalloproteinase 9), resistin, and IL-1β (interleukin 1β) in saliva. Statistically significant, positive correlations between hepatic steatosis and the concentration of MMP-2 (matrix metalloproteinase 2), resistin, and IL-1β in saliva were also found. Statistically significant positive correlations were also found between the concentration of resistin in saliva and the concentration of ALT (alanine aminotransferase) and GGTP (gamma-glutamyl transpeptidase) in serum. MMP-2, IL-1β, and resistin may be potential markers of NAFLD development, assessed in saliva. However, further research is needed because this is the first study to evaluate the concentrations of the selected pro-inflammatory parameters in the saliva of patients with NAFLD.https://www.mdpi.com/1422-0067/24/3/2891non-alcoholic fatty liver disease (NAFLD)NAFLD diagnosisobesitysalivaNAFLD biomarkerspro-inflammatory cytokines
spellingShingle Beata Zyśk
Lucyna Ostrowska
Joanna Smarkusz-Zarzecka
Katarzyna Witczak-Sawczuk
Agnieszka Gornowicz
Anna Bielawska
Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
International Journal of Molecular Sciences
non-alcoholic fatty liver disease (NAFLD)
NAFLD diagnosis
obesity
saliva
NAFLD biomarkers
pro-inflammatory cytokines
title Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
title_full Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
title_fullStr Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
title_full_unstemmed Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
title_short Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
title_sort pro inflammatory adipokine and cytokine profiles in the saliva of obese patients with non alcoholic fatty liver disease nafld a pilot study
topic non-alcoholic fatty liver disease (NAFLD)
NAFLD diagnosis
obesity
saliva
NAFLD biomarkers
pro-inflammatory cytokines
url https://www.mdpi.com/1422-0067/24/3/2891
work_keys_str_mv AT beatazysk proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy
AT lucynaostrowska proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy
AT joannasmarkuszzarzecka proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy
AT katarzynawitczaksawczuk proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy
AT agnieszkagornowicz proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy
AT annabielawska proinflammatoryadipokineandcytokineprofilesinthesalivaofobesepatientswithnonalcoholicfattyliverdiseasenafldapilotstudy